Abstract
Coronavirus disease 2019 (COVID-19), a pandemic that is triggered by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or 2019-nCoV, causes primarily respiratory discomfort along with other mild symptoms/no symptoms, leading to severe illness and death, if proper care is not taken. At present, COVID-19 is the resilient reason for a large number of human casualties worldwide as well as a cause of crucial economic loss posturing global threat. There is a necessity of intensive research to elucidate the pathogenic mechanisms of COVID-19, which would assist in understating the susceptibility towards the infection as well as prompt development of effective prevention and treatment strategies. Over the years, clinical studies have indicated the risk of various pathogenic infections prejudiced due to preexisting chronic diseases as well as ABO blood group types to a larger extent. In line of this, current COVID-19 infection-associated clinical studies intensely endorse the relationship of blood group type of individual and risk of COVID-19 infection. In this chapter, various clinical studies from January 2020 to June 2020 have been summarized to highlight the eminence of ABO blood group and COVID-19 infection susceptibility in human population. These reports evidently support the fact that individuals with A histo blood group were found to be more vulnerable to COVID-19 infection whereas individuals with blood group O were less likely to get infected with virus. To get deeper insight in this fact, many more studies are desirable in order to further explicate the promising protective role of the blood group O and it will be supportive for designing and planning several additional countermeasures against COVID-19 infection.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R (2020) COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 24:91–98. https://doi.org/10.1016/j.jare.2020.03.005
Cooling L (2015) Blood groups in infection and host susceptibility. Clin Microbiol Rev 28(3):801–870. https://doi.org/10.1128/CMR.00109-14
Dean L, Dean L (2005) Blood groups and red cell antigens, vol 2. NCBI, Bethesda, MD
Ruvoën-Clouet N, Ganière JP, André-Fontaine G, Blanchard D, Le Pendu J (2000) Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. J Virol 74(24):11,950–11,954. https://doi.org/10.1128/jvi.74.24.11950-11954
Issitt PD, Anstee DJ (1998) Applied blood group serology, vol 175. Montgomery Scientific Publications, Durham, NC
Mollicone R, Caillard T, Le Pendu J, Francois A, Sansonetti N, Villarroya H, Oriol R (1988) Expression of ABH and X (Lex) antigens on platelets and lymphocytes. Blood 71(4):1113–1119
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Müller MA (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052
Park AC, Tortorici YJ, Wall MA, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181(2):281–292. https://doi.org/10.1016/j.cell.2020.02.058
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273. https://doi.org/10.1038/s41586-020-2012-7
Watanabe Y, Bowden TA, Wilson IA, Crispin M (2019) Exploitation of glycosylation in enveloped virus pathobiology. Biochim Biophys Acta General Subjects 1863(10):1480–1497. https://doi.org/10.1016/j.bbagen.2019.05.012
Inoue Y, Tanaka N, Tanaka Y, Inoue S, Morita K, Zhuang M et al (2007) Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J Virol 81(16):8722–8729. https://doi.org/10.1128/JVI.00253-07
Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P (2005) Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 102(33):11876–11881. https://doi.org/10.1073/pnas.0505577102
Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C (2008) SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res 18(2):290–301. https://doi.org/10.1038/cr.2008.15
Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F (2010) Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol 84(24):12658–12664. https://doi.org/10.1128/JVI.01542-10
Cidl K, Strelcova L, Znojil V, Vachi J (1996) Angiotensin I-converting enzyme (ACE) polymorphism and ABO blood groups as factors codetermining plasma ACE activity. Exp Hematol 24(7):790
Lee B, Dickson DM, deCamp AC, Ross Colgate E, Diehl SA, Uddin MI et al (2018) Histo–blood group antigen phenotype determines susceptibility to genotype-specific rotavirus infections and impacts measures of rotavirus vaccine efficacy. J Infect Dis 217(9):1399–1407
Guillon P, Clément M, Sébille V, Rivain JG, Chou CF, Ruvoën-Clouet N, Le Pendu J (2008) Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology 18(12):1085–1093. https://doi.org/10.1093/glycob/cwn093
Keyaerts E, Vijgen L, Pannecouque C, Van Damme E, Peumans W, Egberink H et al (2007) Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res 75(3):179–187. https://doi.org/10.1016/j.antiviral.2007.03.003
Singh RS, Walia AK (2018) Lectins from red algae and their biomedical potential. J Appl Phycol 30:1833–1858. https://doi.org/10.1007/s10811-017-1338-5
Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y, He Y, Sun B, Wei M, Yang G, Wang X, Zhang L, Zhou X, Xing M, Wang PG Relationship between the ABO blood group and the COVID-19 susceptibility. Clin Infect Dis:ciaa1150. https://doi.org/10.1093/cid/ciaa1150
Li J, Wang X, Chen J, Cai Y, Deng A, Yang M (2020) Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol 190(1):24–27. https://doi.org/10.1111/bjh.16797
Aljanobi GA, Alhajjaj AH, Alkhabbaz FL, Al-Jishi JM (2020) The relationship between ABO blood group type and the COVID-19 susceptibility in Qatif Central Hospital, Eastern Province, Saudi Arabia: a retrospective cohort study. Open J Intern Med 10(2):232–238. https://doi.org/10.4236/ojim.2020.102024
Abdollahi A, Mahmoudi-Aliabadi M, Mehrtash V, Jafarzadeh B, Salehi M (2020) The novel coronavirus SARS-CoV-2 vulnerability association with ABO/Rh blood types. Iran J Pathol 15(3):156–160. https://doi.org/10.30699/ijp.2020.125135.2367
Göker H, AladağKarakulak E, Demiroğlu H, AyazCeylan ÇM, Büyükaşik Y, Inkaya A (2020) The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci 50(4):679–683. https://doi.org/10.3906/sag-2005-2395
Wu Y, Feng Z, Li P, Yu Q (2020) Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clin Chim Acta 509:220–223. https://doi.org/10.1016/j.cca.2020.06.026
Peng M, Huang S, Zhu S, Chen C, Qin J, He M, Zhao Q (2020) Distribution of ABO blood groups and association to low risk of COVID-19 infection in patients. Res Square. https://doi.org/10.21203/rs.3.rs-32315/v1
Alkout TA, Alkout AM (2020) ABO blood groups among Coronavirus disease 2019 patients. Iberoamerican J Med. (Ahead of Print). https://doi.org/10.1101/2020.03.11.20031096
Eagan R, Twigg HL III, French N, Musaya J, Day RB, Zijlstra EE et al (2007) Lung fluid immunoglobulin from HIV-infected subjects has impaired opsonic function against pneumococci. Clin Infect Dis 44(12):1632–1638. https://doi.org/10.1086/518133
Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P et al (2020) Genome-wide association study of severe Covid-19 with respiratory failure. N Engl J Med. https://doi.org/10.1056/NEJMoa2020283
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ghosh, N., Kumar, V., Ganju, L., Kumar, B., Srivastava, S., Garg, I. (2021). An Insight into Association Between COVID-19 Infection and ABO Blood Group. In: Sobti, R.C., Dhalla, N.S., Watanabe, M., Sobti, A. (eds) Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications. Springer, Singapore. https://doi.org/10.1007/978-981-16-5105-2_24
Download citation
DOI: https://doi.org/10.1007/978-981-16-5105-2_24
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-5104-5
Online ISBN: 978-981-16-5105-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)